-
Mashup Score: 65
A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.
Source: scopeblog.stanford.eduCategories: General Medicine News, General HCPsTweet
A few closely related drugs, all aimed at treating Alzheimer’s disease, don’t appear to be helping patients much if at all. Stanford Medicine neurologist Mike Greicius, MD, explains why. #Alzheimers #Medicine https://t.co/kcBlmODq3V